BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Prognosis
420 results:

  • 1. Geriatric nutritional risk index predicts the prognosis of gastric cancer patients treated with immune checkpoint inhibitors.
    Liu B; Zhang L
    Medicine (Baltimore); 2024 Apr; 103(17):e37863. PubMed ID: 38669385
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies-experience from a tertiary care center in Germany.
    Reese M; Eichelmann AK; Nowacki TM; Pascher A; Sporn JC
    Langenbecks Arch Surg; 2024 Apr; 409(1):113. PubMed ID: 38589714
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long-term monitoring of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the MALT1 gene.
    Iwamuro M; Takenaka R; Miyahara K; Okanoue S; Yoshioka M; Sakaguchi C; Yamamoto K; Kawai Y; Toyokawa T; Tanaka T; Otsuka M
    Sci Rep; 2024 Feb; 14(1):4953. PubMed ID: 38418651
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive Value of a New Muscle Parameter in Patients with Resectable gastric cancer: A Pooled Analysis of Three Prospective Trials.
    Zhong Q; Huang JB; Lu J; Xue LW; Lin GT; Xie JW; Lin JX; Zheng CH; Huang CM; Li P
    Ann Surg Oncol; 2024 May; 31(5):3005-3016. PubMed ID: 38270825
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Risk factors for early recurrence after radical gastrectomy followed by adjuvant chemotherapy for stage II or III gastric cancer: a multicenter, retrospective study.
    Yagi S; Kumagai K; Nunobe S; Ishizuka N; Yamaguchi T; Imai Y; Tsuda M; Haruta S; Fukunaga H; Yamada T; Goto M
    Jpn J Clin Oncol; 2024 Apr; 54(4):403-415. PubMed ID: 38251775
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Usefulness of the preoperative inflammation-based prognostic score and the ratio of visceral fat area to psoas muscle area on predicting survival for surgically resected adenocarcinoma of the esophagogastric junction.
    Uchida S; Sohda M; Tateno K; Watanabe T; Shibasaki Y; Nakazawa N; Kuriyama K; Sano A; Yokobori T; Sakai M; Ogawa H; Shirabe K; Saeki H
    Esophagus; 2024 Apr; 21(2):157-164. PubMed ID: 38112929
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Implication of perineural invasion in patients with stage II gastric cancer.
    Luo D; Wen YE; Chen H; Deng Z; Zheng J; Chen S; Peng J; Lian L
    World J Surg Oncol; 2023 Nov; 21(1):372. PubMed ID: 38031044
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable gastric cancer : prognosis Prediction for Resectable GC.
    Guo S; Wang E; Wang B; Xue Y; Kuang Y; Liu H
    Ann Surg Oncol; 2024 Mar; 31(3):2078-2089. PubMed ID: 37996637
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The role of the multidisciplinary tumor board after endoscopic resection of malignant tumors: is it worth it?
    Kouladouros K; Centner M; Reissfelder C; Belle S; Kähler G
    Surg Endosc; 2024 Feb; 38(2):607-613. PubMed ID: 37991571
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic value of hyperthermic intraperitoneal chemotherapy in gastric cancer with synchronous peritoneal metastases: a real-world retrospective study.
    Guo J; Deng Z; Jin L; Yin S; Xiong Z; Wang C; Chen H; Luo D; Huang D; Peng J; Chen S; Lian L
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17881-17896. PubMed ID: 37947869
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With gastric cancer Who Receive Curative Surgery.
    Aoyama T; Hashimoto I; Maezawa Y; Hara K; Komori K; Otani K; Kazama K; Sawazaki S; Numata M; Kamiya N; Kato A; Yamada T; Nagasawa S; Kawahara S; Cho H; Morita J; Tanabe M; Yukawa N; Saito A; Rino Y; Ogata T; Oshima T
    Anticancer Res; 2023 Nov; 43(11):5181-5187. PubMed ID: 37909998
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study.
    Sun C; Niu P; Zhang X; Zhao L; Wang W; Luan X; Han X; Chen Y; Zhao D
    BMC Cancer; 2023 Oct; 23(1):996. PubMed ID: 37853387
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score-matched analysis.
    Huang X; Fang J; Huang L; Chen H; Chen H; Chai T; Ye Z; Chen H; Xu Q; Du Y; Yu P
    Gastric Cancer; 2023 Nov; 26(6):1040-1050. PubMed ID: 37768447
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Serum extracellular vesicles with NSD1 and FBXO7 mRNA as novel biomarkers for gastric cancer.
    Wang Z; Ding J; Xiao Y; Xiao K; Su P; Dong Z; Zhang Y
    Clin Biochem; 2023 Oct; 120():110653. PubMed ID: 37742869
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Study of immunophenotypic characteristics, clinicopathological parameters and prognosis in gastric cancer microenvironment].
    Wu Y; Chen YQ; Shi TG; Tan NJ; Chen WC
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2786-2794. PubMed ID: 37723053
    [No Abstract]    [Full Text] [Related]  

  • 16. Validity of Endoscopic Submucosal Dissection for gastric cancer Diagnosed as Differentiated Adenocarcinoma Before Treatment Regardless of Lesion Size.
    Nomura K; Hoteya S; Ochiai Y; Okamura T; Suzuki Y; Hayasaka J; Mitsunaga Y; Tanaka M; Fuchinoue K; Odagiri H; Yamashita S; Matsui A; Kikuchi D
    Turk J Gastroenterol; 2023 Nov; 34(11):XXXX. PubMed ID: 37681270
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Neoadjuvant docetaxel, oxaliplatin plus capecitabine versus oxaliplatin plus capecitabine for patients with locally advanced gastric adenocarcinoma: long-term results of a phase III randomized controlled trial.
    Tian Y; Yang P; Guo H; Liu Y; Zhang Z; Ding P; Zheng T; Deng H; Ma W; Li Y; Fan L; Zhang Z; Wang D; Zhao X; Tan B; Liu Y; Zhao Q
    Int J Surg; 2023 Dec; 109(12):4000-4008. PubMed ID: 37678277
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cyclin D1 expression, clinicopathological characteristics, and 2-year survival rate of gastric cancer in Cipto Mangunkusumo General Hospital.
    Cahyanur R; Utari AP; Rahadiani N
    Niger J Clin Pract; 2023 Aug; 26(8):1057-1062. PubMed ID: 37635596
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Textbook outcome contributes to long-term prognosis in older adults with gastric cancer.
    Morito A; Iwatsuki M; Maeda Y; Mitsuura C; Hara Y; Matsumoto C; Toihata T; Kosumi K; Eto K; Baba Y; Iwagami S; Miyamoto Y; Yoshida N; Baba H
    Langenbecks Arch Surg; 2023 Aug; 408(1):324. PubMed ID: 37597037
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
    Wu LL; Cai MZ; Wang BG; Deng JY; Ke B; Zhang RP; Liang H; Wang XN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jul; 26(7):680-688. PubMed ID: 37583026
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 21.